These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33890459)

  • 21. [Nuclear medicine imaging: new radiotracers and future techniques].
    Semah F
    Neurochirurgie; 2008 May; 54(3):231-5. PubMed ID: 18440564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET radiotracers for molecular imaging in the brain: past, present and future.
    Zimmer L; Luxen A
    Neuroimage; 2012 Jun; 61(2):363-70. PubMed ID: 22222719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotracers for imaging of Parkinson's disease.
    Abbasi Gharibkandi N; Hosseinimehr SJ
    Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases.
    Narayanaswami V; Drake LR; Brooks AF; Meyer JH; Houle S; Kilbourn MR; Scott PJH; Vasdev N
    ACS Chem Neurosci; 2019 Apr; 10(4):1867-1871. PubMed ID: 30789704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET).
    Banister SD; Manoli M; Kassiou M
    J Labelled Comp Radiopharm; 2013; 56(3-4):215-24. PubMed ID: 24285328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Basic Principles of FDG-PET/CT Imaging.
    Basu S; Hess S; Nielsen Braad PE; Olsen BB; Inglev S; Høilund-Carlsen PF
    PET Clin; 2014 Oct; 9(4):355-70, v. PubMed ID: 26050942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy.
    Witney TH; Blower PJ
    Cancer Imaging; 2021 Jan; 21(1):18. PubMed ID: 33516256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review on production of 89Zr in a medical cyclotron for PET radiopharmaceuticals.
    Kasbollah A; Eu P; Cowell S; Deb P
    J Nucl Med Technol; 2013 Mar; 41(1):35-41. PubMed ID: 23327781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiopharmaceutical chemistry for positron emission tomography.
    Li Z; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matching chelators to radiometals for radiopharmaceuticals.
    Price EW; Orvig C
    Chem Soc Rev; 2014 Jan; 43(1):260-90. PubMed ID: 24173525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of PET radiopharmaceuticals at the academia-industry interface.
    Bernard-Gauthier V; Collier TL; Liang SH; Vasdev N
    Drug Discov Today Technol; 2017 Nov; 25():19-26. PubMed ID: 29233263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography radiotracers for imaging hypoxia.
    Wuest M; Wuest F
    J Labelled Comp Radiopharm; 2013; 56(3-4):244-50. PubMed ID: 24285331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sweetening pharmaceutical radiochemistry by (18)f-fluoroglycosylation: a short review.
    Maschauer S; Prante O
    Biomed Res Int; 2014; 2014():214748. PubMed ID: 24991541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives.
    Olivas Arroyo C
    Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boron reagents for divergent radiochemistry.
    Wilson TC; Cailly T; Gouverneur V
    Chem Soc Rev; 2018 Sep; 47(18):6990-7005. PubMed ID: 30140795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Trends Cardiovasc Med; 2020 Jan; 30(1):11-19. PubMed ID: 30824163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.
    Dahl K; Halldin C; Schou M
    Clin Transl Imaging; 2017; 5(3):275-289. PubMed ID: 28596949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High--valent technetium chemistry-new opportunities for radiopharmaceutical developments.
    Braband H
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):270-4. PubMed ID: 24347394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET tracers and radiochemistry.
    Schlyer DJ
    Ann Acad Med Singap; 2004 Mar; 33(2):146-54. PubMed ID: 15098627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.